与CAR T细胞相关的二次恶性瘤挑战了当前的药监概念
Philipp Berg1, Gabriele Ruppert-Seipp1, Susanne Müller1
1Safety of Biomedicines and Diagnostics, Paul-Ehrlich-Institut, Langen, Germany.
EMBO molecular medicine
|January 6, 2025
概括
化学抗原受体T细胞 (CAR T) 治疗后的二次T细胞恶性瘤是一个越来越令人担忧的问题. 由于患者因素和有限的数据,评估因果关系是复杂的,需要逐案分析.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药物监督 药物监督 药物监督
背景情况:
- 化学抗原受体T细胞 (CAR T) 疗法已经彻底改变了癌症治疗.
- 越来越多的报告将CAR T治疗与二次T细胞恶性瘤联系起来.
- 已建立的药物监测方法在评估这些先进疗法的因果关系方面扎.
研究的目的:
- 要总结二次恶性瘤在CAR T治疗后的病例报告.
- 讨论这些事件的因果关系评估的理由和挑战.
- 探索影响风险的病理生理机制和产品特定因素.
主要方法:
- 审查和现有案例报告的摘要涉及各种CART产品.
- 分析因果关系评估的挑战,考虑患者和产品特定的因素.
- 讨论潜在的病理生理路径和有助于的因素.
主要成果:
- 因果关系的评估因患者特定的风险和不完整的营销后数据而复杂化.
- 将基因疗法产品整合到宿主基因组中,带来了独特的挑战.
- 由于癌症发展的复杂性,逐个案例的方法是必不可少的.
结论:
- 针对先进疗法药品的药监工作面临重大障碍.
- 检测载体存在,集成部位和基因表达的测试对于准确的评估至关重要.
- 了解促成因素对于提高CAR T疗法的安全性至关重要.
更多相关视频
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
11.6K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
3.3K
相关概念视频
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
01:30Cancer Vaccines
337
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
337
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K